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Alternative lymph node (LN) parameters have been proposed to improve staging in colorectal cancer. This study compared these
alternative parameters with conventional TNM staging in predicting long-term survival in patients undergoing curative resection.
A total of 295 consecutive patients (mean age 70 years; range 39–95; s.d. 10.4) underwent resection for colorectal cancer from 2001
to 2004. Age, sex, primary tumour site, TNM stage and chemotherapy/radiotherapy were recorded. Patients with colon and rectal
cancers were analysed separately for LN parameters: LN total; adequate LN retrieval (X12) and inadequate (o12); total number of
negative LN; total number of positive LN and the ratio of positive LN to total LN (pLNR). Univariate and multivariate survival analysis
was performed. The median number of LN retrieved was 10 (1–57) with adequate LN retrieval in 147 cases (49.8%). For each T and
N stage, inadequate LN retrieval did not adversely affect long-term survival (P40.05). On multivariate analysis, only pLNR was an
independent predictor of overall survival in both colon and rectal cancers (HR 11.65, 95% CI 5.00–27.15, Po0.001 and HR 13.40,
95% CI 3.64–49.10, Po0.001, respectively). Application of pLNR subdivided patients into four prognostic groups. Application of the
pLNR improved patient stratification in colorectal cancer and should be considered in future staging systems.
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Colorectal cancer is one of the commonest malignancies in the
United Kingdom, with the presence of lymph node metastases
being one of the most important prognostic determinants.
Currently, patients with colorectal cancer are staged used the
TNM staging system that divides patients into prognostic groups
according to the growth of the primary tumour, presence of
lymph node metastases and evidence of distant metastatic spread.
Lymph node status is determined by the number of positive lymph
nodes retrieved with prognosis declining as the number of posi-
tive lymph nodes increases: node negative (N0); node positive with
1–3 nodes positive (N1) and node positive with X4 nodes positive
(N2; Sobin and Wittekind, 2002). However, some researchers
believe that TNM may not result in optimal staging and have
proposed alternative lymph node parameters.
One of these alternative parameters focuses on the overall
number of lymph nodes retrieved. Initial work was performed on
node-negative disease, where researchers found that as the number
of lymph nodes examined increased, the disease-free and overall
survival improved (Caplin et al, 1998; Prandi et al, 2002; Le Voyer
et al, 2003; Swanson et al, 2003; Berger et al, 2005; Edler et al, 2007;
Wong et al, 2007). Attention turned to node-positive disease with
a recent systematic review by the National Cancer Institute con-
cluding after analysing over 60000 patients that there was a
positive association between increasing number of lymph nodes
retrieved and survival in stage II and stage III colon cancer (Chang
et al, 2007). As a result, many researchers have tried to determine
the minimum number of lymph nodes that should be retrieved to
ensure accurate staging in colonic cancer, but to date no consensus
has been achieved with recommendations varying from as few as
6 to as many as 40 (Hernanz et al, 1994). Currently, the National
Cancer Institute and the Royal College of Pathologists recommend
a minimum retrieval of 12 (Nelson et al, 2001; Royal College of
Pathologists, 2007).
In direct comparison to TNM staging, Johnson et al (2006),
analysed the relationship between the number of negative lymph
nodes retrieved and long-term survival. Over 20000 patients with
stage III colon cancer who had undergone curative resection were
assessed with stage IIIB and IIIC patients having improved long-
term survival as the number of negative nodes increased.
Unfortunately, this phenomenon was not replicated in stage IIIA
patients, leading the authors to state further research is required to
clarify the relationship between total number of negative lymph
nodes and survival.
The ratio between metastatic and examined lymph nodes (the
positive lymph node ratio; pLNR) has been shown to identify
prognostic subgroups within gastric and oesophageal cancer
patients (Marchet et al, 2007; Mariette et al, 2008). In one of these
studies, the authors retrospectively analysed approximately 2000
patients that had undergone radical resection for gastric carcinoma
at different centres. After multivariate analysis pLNR, but not
N stage, was an independent prognostic factor that was also inde-
pendent of the extent of lymphadenectomy. Only a few studies
have analysed pLNR in colon cancer, with prognosis declining as
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spLNR increased (De Ridder et al, 2006; Lee et al, 2007). However,
in one of these studies, pLNR was only found to be significant if
the lymph node retrieval was 415, suggesting adequate lymph
node retrieval to be of greater importance than pLNR.
Unlike patients with colonic cancer, patients with rectal cancers
are routinely considered for neoadjuvant chemo/radiotherapy
before undergoing surgical resection. In addition to shrinking the
primary tumour and reducing the risk of local recurrence after
surgery, radiotherapy may also decrease the number of local
lymph nodes (Wichmann et al, 2002). As a consequence there has
been limited work assessing the minimum lymph node retrieval
number in rectal cancer, with no definitive figure proposed.
Despite this, the Royal College of Pathologists guidelines state that
a mean number of 12 lymph nodes should be retrieved with no
specific guidelines for rectal or neoadjuvant therapy and the
College of American Pathologists also suggest a minimum retrieval
of 12 lymph nodes (Royal College of Pathologists, 2007; National
Comprehensive Cancer Network, 2009).
This study aimed to compare these alternative approaches to
staging of lymph nodes in colorectal cancer and to clarify their
influence on long-term survival in node-negative and node-
positive patients undergoing curative resection.
MATERIALS AND METHODS
A total of 295 consecutive patients that underwent curative
resection for colorectal cancer in two centres between 2001 and
2004 were identified from a departmental prospective database.
Curative resection was defined by pathological clear margins on
the resected specimen with no evidence of metastatic spread on
preoperative imaging of chest, abdomen and pelvis. After resec-
tion, the patients entered a follow-up surveillance programme with
out-patient clinic appointments: 3 and 6 months postoperative;
then yearly thereafter. At each appointment, they underwent clini-
cal history and examination with testing for carcinoembryonic
antigen, liver function and bone markers. In addition, they had
a surveillance colonoscopy and contrast enhanced CT at 1 and
5 years. At the time of this study, all patients were participating in
the follow-up programme with a median follow-up of 4 years
(range 0.1–6.9 years).
Each patient had their age, sex, site of primary tumour (colon
or rectum) and their TNM stage recorded. Neoadjuvant chemo-
therapy and/or radiotherapy and adjuvant chemotherapy were
documented. In relation to lymph node retrieval, the following
variables were calculated separately for colonic and rectal surgery:
the total number of lymph nodes (LN total) and subsequently,
adequate retrieval (X12) and inadequate (o12); the total number
of negative lymph nodes (LN negative) and total number of
positive lymph nodes (LN positive) and the ratio of positive lymph
nodes to total lymph nodes (pLNR).
To determine the influence of lymph node retrieval on long-term
outcome, univariate and multivariate survival analysis was per-
formed using a stepwise backward procedure to derive a final model
of the variables that had a significant independent relationship with
survival. To remove a variable from the model, the corresponding
P value had to be greater than 0.10. Analysis was performed using
SPSS software version 15.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Patient demographics and TNM staging
The mean age in this study was 70 years (range 39–95, s.d. 10.4)
with a slight male preponderance (163 men, 132 women). Colonic
resections accounted for the majority of resections (n¼195,
66.1%) with 84 patients (28.5%) having undergone any form of
chemo/radiotherapy.
Tables 1 and 2 display the demographics, TNM staging and the
number of patients undergoing chemo/radiotherapy for colon and
rectal cancers.
Lymph node retrieval
Of the 295 cases, adequate lymph node retrieval was only achieved
in 147 cases (49.8%). For colon cancers, adequate retrieval occur-
red in 48.2% of patients whereas in rectal, 53% of patients had at
least 12 lymph nodes removed. For each T and N stage, inadequate
Table 1 Patient demographics, TNM staging, chemotherapy and their
influence on long-term survival in patients undergoing curative resection
for colon cancer
n 5-year survival (%) P value
Age
39–70 years 84 43.1 71.5 0.013
a
70–92 years 111 56.9 55.2
Sex
Male 100 51.3 66.3 0.090
Female 195 48.7 60.7
T stage
T1 15 7.7 80.0 o0.001
a
T2 20 10.3 71.0
T3 105 53.8 65.1
T4 55 28.2 35.0
N stage
N0 120 61.5 72.4 o0.001
a
N1 49 25.1 47.2
N2 26 13.3 22.9
Chemotherapy
Yes 53 26.7 58.7 0.459
No 143 73.3 65.7
aIndicates log-rank test.
Table 2 Patient demographics, TNM staging, chemo/radiotherapy and
their influence on long-term survival in patients undergoing curative
resection for rectal cancer
n 5-year survival (%) P value
Age
39–70 years 57 57.0 76.0 0.151
70–92 years 43 43.0 63.4
Sex
Male 63 63.0 66.2 0.246
Female 37 37.0 77.8
T stage
T1 10 10.0 90.0 0.050
T2 29 29.0 86.7
T3 53 53.0 58.0
T4 8 8.0 75.0
N Stage
N0 60 60.0 81.6 0.040
a
N1 22 22.0 60.6
N2 18 18.0 43.5
Chemotherapy/radiotherapy
Yes
b 31 31.0 67.0 0.537
No 69 69.0 72.0
aIndicates log-rank test.
bNeoadjuvant therapy was performed in 21 cases.
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slymph node retrieval did not adversely affect long-term survival
(Kaplan–Meier log-rank test P40.050).
In relation to the other lymph node parameters, total number of
lymph nodes retrieved and total number of negative lymph nodes
did not influence overall survival in either colon or rectal cancers,
whereas the remaining lymph node variables analysed, including
N stage, achieved statistical significance (Table 3). On multivari-
ate analysis, only pLNR was an independent predictor of overall
survival in both colon and rectal cancers (HR 11.65, 95% CI 5.00–
27.15, Po0.001 and HR 13.40, 95% CI 3.64–49.10, Po0.001,
respectively).
Inclusion of age into the multivariate model for colon cancers
found both pLNR and age to be independent predictors of survival
(HR 11.89, 95% CI 5.13–27.53, Po0.001 and HR 1.88, 95% CI
1.17–3.03, P¼0.008, respectively).
Subdivision of patients according to pLNR
The pLNR was subdivided into four groups according to a previous
work (Berger et al, 2005): o0.05; 0.05–0.19; 0.20–0.39 and 0.40–1.0.
In both colon and rectal cancer patients, overall survival signifi-
cantly decreased as pLNR increased (Po0.001; Figures 1 and 2).
DISCUSSION
Determination of the optimal approach to quantifying lymph node
status in colorectal cancer will ensure accurate patient staging,
allowing appropriate adjuvant treatment planning and calculation
of long-term prognosis. This study is one of the first to directly
compare several of the proposed approaches in colon and rectal
cancer, finding the positive lymph node ratio to be the optimal
staging modality.
The total number of lymph nodes retrieved, total number of
negative nodes and total number of positive nodes have been
proposed by different researchers to optimally stage patients with
colon cancer. In this study we analysed rectal cancers as well as
colon cancers and found that none of these factors were significant
on multivariate analysis. In addition, inadequate lymph node
retrieval, as defined by NCI, occurred in approximately 50% of
cases in this study. Despite this, no detriment to long-term survival
was found in either node-negative or node-positive patients.
There are many factors potentially influencing lymph node
retrieval including grade and specialty of surgeon, neoadjuvant
radiotherapy and/ or chemotherapy and technique of analysis
by the pathologist. There are also naturally occurring variables,
specifically the age and sex of the patient. Lastly, the type of
resection appears to be important with right-sided resections
potentially yielding higher numbers of lymph nodes. With all these
variables it is not surprising that the above lymph node parameters
have not been found to optimally stage colorectal cancer patients.
Indeed, this study is not the only one to document no detriment to
survival with inadequate node retrieval. A recent study in 2007
looked at over 30000 patients from the National Surveillance,
Epidemiology and End-Results (SEER) Medicare-linked database.
These patients were from four hospitals that had different lymph
Table 3 The influence of lymph node retrieval parameters on long-term survival after curative colonic and rectal cancer resections: univariate and
multivariate analysis
Colonic resections Rectal resections
Univariate P value Multivariate P value HR (95% CI) Univariate P value Multivariate P value HR (95% CI)
LN total 0.169 0.251
Adequate LN retrieval 0.065 0.572
LN negative 0.065 0.065
LN positive o0.001* 0.912 0.99 (0.87–1.13) o0.001* 0.839 0.96 (0.65–1.43)
Positive LNR o0.001* o0.001* 11.65 (5.00–27.15) o0.001* o0.001* 13.4 (3.64–49.10)
N stage o0.001* 0.642 1.13 (0.67–1.89) 0.004* 0.640 1.2 (0.54–2.72)
*Po0.05
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Figure 1 Differences in overall survival in patients undergoing curative
resection for colon cancer when classified by positive lymph node ratios.
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Figure 2 Differences in overall survival in patients undergoing curative
resection for rectal cancer when classified by positive lymph node ratios.
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snode retrieval rates, and despite the disparity, the authors found
no significant survival difference (Wong et al, 2007).
The positive lymph node ratio may overcome some of the
limitations of the other parameters as it divides node-positive
patients into ranges, although not relying on one outcome vari-
able. This may also overcome the difficulty of proposing a
minimum lymph node retrieval number in rectal cancer patients
that have undergone neoadjuvant therapy. In addition, it changes
prognostic stratification. In patients with colon cancer in this
study that were staged as N1, the 5-year survival was 47.2%.
Application of the positive lymph node ratio to this group
subdivides these patients: in those patients with the lowest posi-
tive lymph node ratios, their 5-year survival has improved to 58%,
and in those with the highest positive lymph node ratio, their
survival has reduced to 22%. For N2 patients, the 5-year survival
difference between the lowest and highest lymph node ratios was
33%. This prognostic stratification change has also been com-
mented on by the two previous papers assessing positive lymph
node ratio in colon cancer.
Berger et al (2005) assessed this ratio in patients with stage II
and stage III colonic cancer that had been specifically recruited for
a chemotherapy trial. The authors found an increasing positive
lymph node ratio resulted in poorer overall and disease-free
survival. Furthermore, 5-year survival difference of 19% in N1
patients between the lowest and the highest ratios was docu-
mented that increased to 28% in N2 patients. However, the
influence of positive lymph node ratio was not significant when
lymph node retrieval was o15, leading the authors to conclude
that lymph node retrieval is the more important factor. Our study
methodology differs, in that we have analysed for any effect of a
patient receiving chemotherapy, included rectal cancers and had a
high rate of inadequate lymph node retrieval. However, we still
found positive lymph node ratio to be independently prognostic
in all patients, something that N staging could not achieve on
multivariate analysis.
Our findings are supported by De Ridder et al (2006), who
analysed patients with node-positive colonic and rectal cancers.
This time, only two subdivisions were made with a pLNR of 0.4
taken as the threshold: patients with ratios greater than 0.4 had a
5-year survival of 25% vs 56% in the groups with lower ratios. This
was compared to the N1 and N2 staged groups that had 5-year
survival of 54 and 28%, respectively. These results led the authors
to conclude that application of the positive lymph node ratio led
to improved prognostic separation and should be used in future
staging systems. As the authors only assessed two subdivisions, no
comment can be made on whether greater disparity would have
been found with further subdivisions.
Further work is underway to determine the appropriate sub-
divisions of the positive lymph node ratio in node-positive
patients. It may be that the four subdivisions used here can be
optimised, providing more prognostic information for clinicians
and patients. Also, the application of the ratio in node-negative
patients requires clarification. Perhaps it may have a role in
identifying ‘high risk’ patients that should be considered for
chemotherapy.
CONCLUSION
Calculation of the positive lymph node ratio optimises patient
staging and alters patient stratification, irrespective of lymph node
retrieval numbers in both colon and rectal cancers.
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